Skip to content

Clinical trials

Overweight trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Poland Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20121
20141
20152
20162
20171
20183
20192
20203
20212
20222
20238
20244
202518
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting24
Active, not recruiting15
Unknown status6
Not yet recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S14
Eli Lilly and Company12
Amgen5
Poznan University of Life Sciences4
Hoffmann-La Roche3
Medical University of Warsaw3
Pfizer3
Ascletis Pharma (China) Co., Limited2
AstraZeneca2
Kailera2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight74
Obesity72
Diabetes Mellitus, Type 214
Inflammation6
Metabolic Syndrome6
Diabetes Mellitus5
Body Weight4
Nutrition Disorders4
Sleep Apnea, Obstructive4
Glucose Metabolism Disorders3

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.